Background Oriented Schlieren (BOS) Visualization for Evaluation of Risk in Aerosol-Generating Procedures

用于评估气溶胶生成程序风险的背景导向纹影 (BOS) 可视化

基本信息

  • 批准号:
    10545023
  • 负责人:
  • 金额:
    $ 20.89万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2022
  • 资助国家:
    美国
  • 起止时间:
    2022-01-01 至 2024-11-30
  • 项目状态:
    已结题

项目摘要

Project Summary Aerosol-generating procedures (AGPs) are medical procedures that produce aerosols that can be laden with pathogens if the patient has a viral infection, such as SARS-CoV-2 or influenza. These aerosols pose a significant risk to health care workers, as they can linger in the air for extended periods of time and are small enough to bypass ordinary surgical masks. There is currently no established, unambiguous way to evaluate the risks to healthcare workers associated with a specific AGP, nor is there a rigorous method by which to assess a proposed risk-mitigation strategy. To address this gap, a flow visualization technique must be developed that can be applied in a clinical setting during actual medical procedures and is capable of detecting aerosol-laden flows produced by AGPs or potential AGPs. In this R21 proposal, we will adapt background-oriented schlieren (BOS) visualization, a method from fluid mechanics, into a technique that can be applied to study flows produced by AGPs. The R21 project is high risk with no published preliminary data, but the PIs have successfully demonstrated visualziation of aerosols produced by jet ventilation, a specific type of AGP, using BOS in a proof-of-concept experiment. The proposed work is significant and timely, as assessment of the risk associated with AGPs is extremely important in the context of the COVID-19 pandemic. We will use the novel BOS technique to assess risks and evaluate mitigation strategies for three specific AGPs in both ex vivo and in vivo conditions. Specific Aim 1: Develop a human-scale BOS system and establish a procedure for evaluating the risk of AGPs in a clinical setting. Specific Aim 2: Quantify the risk of aerosol exposure under different simulated and in-vivo conditions, and identify strategies to mitigate the risks. The significance and impact of the proposed research will be in developing a tool for unambiguously evaluat- ing the risks associated with AGPs in realistic clinical settings, and urgently-needed risk assessments for three specific AGPs and experimentally verified risk mitigation strategies for each.
项目摘要 气溶胶产生程序(AGP)是一种产生气溶胶的医疗程序,这种程序可能会携带 如果患者有病毒感染,如SARS-CoV-2或fl病毒感染,就会感染病原体。这些气雾剂构成了一种明显的fi不能 对医护人员的风险,因为他们可以在空气中停留很长一段时间,而且足够小, 绕过普通的医用口罩。目前还没有确定的、明确的方法来评估 与特定fic agp相关的医护人员,也没有一种严格的方法来评估建议的 风险缓解战略。为了解决这一差距,必须开发一种可应用的flow可视化技术 在实际医疗过程中的临床环境中,能够检测产生的气雾剂flOWS 通过AGP或潜在的AGP。 在这个R21方案中,我们将采用flUID中的一种方法--面向背景的纹影可视化 力学,转化为一种可用于研究AGP产生的flOW的技术。R21项目很高 风险,没有公布的初步数据,但PI已经成功地展示了气溶胶的可视化 由喷射通风公司生产,这是一种特殊的fic型agp,在概念验证实验中使用了bos。建议数 这项工作显然是不可能和及时的,因为评估与fi相关的风险在 新冠肺炎大流行的背景下。我们将使用新的BOS技术来评估风险和评估缓解 体外和体内条件下三种fic-AGP的策略。 Speciific目标1:开发一个人类规模的BOS系统,并建立评估风险的程序 在临床环境中的应用。 SPECIfic目标2:量化不同模拟和体内条件下气溶胶暴露的风险, 并确定降低风险的策略。 拟议研究的重要意义和影响将是开发一种工具,用于明确评估--fi 在现实的临床环境中确定与AGP相关的风险,并对三个国家进行迫切需要的风险评估 SPECIfic AGP并通过实验验证了每个AGP的风险缓解策略。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Nelson Scott Howard其他文献

R126: Pediatric Tonsil Size: Objective vs. Subjective Measurements
  • DOI:
    10.1016/j.otohns.2007.06.462
  • 发表时间:
    2007-08-01
  • 期刊:
  • 影响因子:
  • 作者:
    Nelson Scott Howard;Scott E. Brietzke
  • 通讯作者:
    Scott E. Brietzke

Nelson Scott Howard的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Nelson Scott Howard', 18)}}的其他基金

Background Oriented Schlieren (BOS) Visualization for Evaluation of Risk in Aerosol-Generating Procedures
用于评估气溶胶生成程序风险的背景导向纹影 (BOS) 可视化
  • 批准号:
    10354549
  • 财政年份:
    2022
  • 资助金额:
    $ 20.89万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 20.89万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 20.89万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 20.89万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 20.89万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 20.89万
  • 项目类别:
    Standard Grant
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 20.89万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 20.89万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 20.89万
  • 项目类别:
    EU-Funded
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 20.89万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 20.89万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了